PH14074A - Benz(g)-isoquinoline derivatives and pharmaceutical compositions containing same - Google Patents

Benz(g)-isoquinoline derivatives and pharmaceutical compositions containing same

Info

Publication number
PH14074A
PH14074A PH19950A PH19950A PH14074A PH 14074 A PH14074 A PH 14074A PH 19950 A PH19950 A PH 19950A PH 19950 A PH19950 A PH 19950A PH 14074 A PH14074 A PH 14074A
Authority
PH
Philippines
Prior art keywords
benz
pharmaceutical compositions
compositions containing
containing same
isoquinoline derivatives
Prior art date
Application number
PH19950A
Other languages
English (en)
Inventor
J Bastian
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH863276A external-priority patent/CH622783A5/de
Priority claimed from CH863176A external-priority patent/CH622782A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH14074A publication Critical patent/PH14074A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/08Aza-anthracenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH19950A 1976-07-06 1977-07-05 Benz(g)-isoquinoline derivatives and pharmaceutical compositions containing same PH14074A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH863276A CH622783A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives
CH863176A CH622782A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives

Publications (1)

Publication Number Publication Date
PH14074A true PH14074A (en) 1981-01-26

Family

ID=25703556

Family Applications (1)

Application Number Title Priority Date Filing Date
PH19950A PH14074A (en) 1976-07-06 1977-07-05 Benz(g)-isoquinoline derivatives and pharmaceutical compositions containing same

Country Status (19)

Country Link
US (1) US4150136A (fr)
JP (1) JPS537681A (fr)
AT (1) AT366369B (fr)
CA (1) CA1094561A (fr)
DE (1) DE2728831A1 (fr)
DK (1) DK285077A (fr)
ES (2) ES460371A1 (fr)
FI (1) FI65242C (fr)
FR (1) FR2357547A1 (fr)
GB (1) GB1582783A (fr)
IE (1) IE45241B1 (fr)
IL (1) IL52449A (fr)
MY (1) MY8400058A (fr)
NL (1) NL7707307A (fr)
NZ (1) NZ184547A (fr)
PH (1) PH14074A (fr)
PT (1) PT66758B (fr)
SE (2) SE7707445L (fr)
SU (1) SU692559A3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325803A (en) * 1964-10-01 1967-06-13 Ibm Deflection control circuit

Also Published As

Publication number Publication date
IL52449A0 (en) 1977-10-31
ES476889A1 (es) 1979-07-16
PT66758B (fr) 1979-03-12
NL7707307A (nl) 1978-01-10
FR2357547A1 (fr) 1978-02-03
SE7707445L (sv) 1978-01-07
DK285077A (da) 1978-01-07
SE8207394D0 (sv) 1982-12-23
FI65242B (fi) 1983-12-30
SU692559A3 (ru) 1979-10-15
GB1582783A (en) 1981-01-14
JPS537681A (en) 1978-01-24
FI65242C (fi) 1984-04-10
ES460371A1 (es) 1979-05-01
IE45241B1 (en) 1982-07-14
PT66758A (fr) 1977-08-01
US4150136A (en) 1979-04-17
AU2677177A (en) 1979-01-11
IL52449A (en) 1981-09-13
ATA477577A (de) 1981-08-15
SE8207394L (sv) 1982-12-23
CA1094561A (fr) 1981-01-27
MY8400058A (en) 1984-12-31
DE2728831A1 (de) 1978-01-19
AT366369B (de) 1982-04-13
FR2357547B1 (fr) 1980-02-15
NZ184547A (en) 1980-08-26
IE45241L (en) 1978-01-06
FI771986A (fr) 1978-01-07

Similar Documents

Publication Publication Date Title
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ184281A (en) Hydantoin derivatives and pharmaceutical compositions
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
ZA773935B (en) Peptide derivatives and pharmaceutical compositions containing same
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ188798A (en) 2-iminoimidazolidine derivatives and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ184808A (en) Heterocyclic compounds and pharmaceutical compositions
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
IL52087A (en) Benzo(c)quinoline derivatives and pharmaceutical compositions containing them
NZ190245A (en) Isoquinoline derivatives and pharmaceutical compositions containing them
NZ186059A (en) 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
GB2010261B (en) Phenoxyalkanolamine derivatives the preparation thereof and pharmaceutical compositions containing them
NZ187195A (en) Benzenesulphonyl-urea derivatives and pharmaceutical compositions
NZ184367A (en) 2-vinyl-chromone derivatives and pharmaceutical compositions
NZ185295A (en) 9-chloroprednisolone derivatives and pharmaceutical compositions
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions